Abstract
Vaccines are biological pharmaceutical products prescribed as prevention of a hypothetical infection. Development of a new vaccine is the result of a long process involving several stages. During all developmental phases, priority is the safety of the new product, which is often used in young infants. The initial research phase lasts 1–5 years and is followed by a clinical and pharmaceutical development phase (preclinical and clinical phases), which can last from 15 to 20 years on average before licensure is obtained. There are, however, exceptions, like the malaria vaccine for which research has been going on for more than 30 years and at least 30 candidate vaccines have been assessed. This chapter summarizes the different phases of vaccine candidate development from preclinical studies to phase 2 vaccine trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Lebron JA, Wolf JJ, Kaplanski CV et al (2005) Ensuring the quality, potency and safety of vaccines during preclinical development. Expert Rev Vaccines 46:855–866
World Health Organization (2003) Guidelines on nonclinical evaluation of vaccines. World Health Organization, Geneva
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (1999) Specifications: test procedures and acceptance criteria for biotechnological/biological products, Q6B
Prescott MJ, Lidster K (2017) Improving quality of science through better animal welfare: the NC3Rs strategy. Lab Anim 46:152–156
Forster R (2012) Study designs for the nonclinical safety testing of new vaccine products. J Pharmacol Toxicol Methods 66:1–7
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Artaud, C., Kara, L., Launay, O. (2019). Vaccine Development: From Preclinical Studies to Phase 1/2 Clinical Trials. In: Ariey, F., Gay, F., Ménard, R. (eds) Malaria Control and Elimination. Methods in Molecular Biology, vol 2013. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9550-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9550-9_12
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9549-3
Online ISBN: 978-1-4939-9550-9
eBook Packages: Springer Protocols